Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	55.50B
Revenue (ttm)	3.03B
Net Income (ttm)	1.96B
Shares Out	301.43M
EPS (ttm)	6.50
PE Ratio	28.33
Forward PE	25.26
Dividend	3.80 (2.04%)
Ex-Dividend Date	n/a

Volume	3,073,511
Average Volume	4,811,554
Open	193.94
Previous Close	186.68
Day's Range	179.60 - 193.94
52-Week Range	132.81 - 282.72
Beta	1.39
RSI	47.21
Earnings Date	Mar 20, 2025

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,223
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2024, SHE:300896's revenue was 3.03 billion, an increase of 5.45% compared to the previous year's 2.87 billion. Earnings were 1.96 billion, an increase of 5.33%.